Clinical Trials Directory

Trials / Completed

CompletedNCT05269511

Efficacy of Chinese Herbal Medicine to Prevent and Treat COVID-19 Close Contacts

Efficacy of Chinese Herbal Medicine to Prevent and Treat COVID-19 Close Contacts: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,163 (actual)
Sponsor
Hong Kong Baptist University · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

This is a randomized, blank-controlled study in adults with household contact exposure to individuals with SARS-CoV-2 infection. All subjects in the study will be household contacts with close exposure to the first household member known to be newly infected with SARS-CoV-2. Subjects in each cohort will be randomly assigned to the Chinese herbal medicine treatment group or blank control group in a 4:1 ratio, followed by 1 week of the treatment period and 2 weeks of follow-up.

Conditions

Interventions

TypeNameDescription
DRUGChinese herbal medicine is in the form of granules (9 g/sachet), which is comprised of ten medicinal herbs.Oral administration, twice per day.

Timeline

Start date
2022-03-14
Primary completion
2022-06-22
Completion
2022-06-22
First posted
2022-03-08
Last updated
2023-04-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05269511. Inclusion in this directory is not an endorsement.